Here's Why Biotech Giant Regeneron Is Soaring
Barron's Bounce: The magazine makes the case that Regeneron is undervalued, and the stock is up big. Plus: A Meryl Witmer, Warren Buffett favorite and the nation's second-largest broadcaster are both on the move.